Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

Y0000199

Ciprofloxacin hydrochloride for peak identification

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

Ciprofloxacin hydrochloride monohydrate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C17H18FN3O3 · HCl · H2O
Número de CAS:
86393-32-0
Peso molecular:
385.82
Número MDL:
MFCD00242856
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
329830881
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

ciprofloxacin

fabricante / nombre comercial

EDQM

aplicaciones

pharmaceutical (small molecule)

Formato

neat

temp. de almacenamiento

2-8°C

cadena SMILES

O.Cl.OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

InChI

1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2

Clave InChI

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Ciprofloxacin hydrochloride for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

PHR1044

Ciprofloxacin HCl, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1167

Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1174

Fluoroquinolonic acid, Pharmaceutical Secondary Standard; Certified Reference Material

1134335

Ciprofloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard

1134324

Análogo de etilendiamino de ciprofloxacino, United States Pharmacopeia (USP) Reference Standard

1278302

Fluoroquinolonic acid, United States Pharmacopeia (USP) Reference Standard

C2190000

Ciprofloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0000198

Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard

C2190050

Ciprofloxacin impurity A, European Pharmacopoeia (EP) Reference Standard

1134459

Ciprofloxacin formamide, United States Pharmacopeia (USP) Reference Standard

1134346

Ciprofloxacin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1134313

Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard

BP930

Ciprofloxacin impurity standard, British Pharmacopoeia (BP) Reference Standard

BP929

Ciprofloxacin hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR2440

Ciprofloxacin formamide, certified reference material, pharmaceutical secondary standard

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Roles of the superoxide dismutase SodB and the catalase KatA in the antibiotic resistance of Campylobacter jejuni.
Sunyoung Hwang et al.
The Journal of antibiotics, 66(6), 351-353 (2013-04-04)
Kathryn E Holt et al.
Proceedings of the National Academy of Sciences of the United States of America, 110(43), 17522-17527 (2013-10-02)
Shigella sonnei is a human-adapted pathogen that is emerging globally as the dominant agent of bacterial dysentery. To investigate local establishment, we sequenced the genomes of 263 Vietnamese S. sonnei isolated over 15 y. Our data show that S. sonnei
E M Jones et al.
The Veterinary record, 173(17), 422-422 (2013-10-08)
Four models are presented investigating risks present on Great Britain (GB) turkey farms in breeding and fattening flocks for ciprofloxacin and cephalosporin resistance. Risk factors for ciprofloxacin resistance in fattening flocks were sourcing of feed from national compounders, antimicrobial use
Julie Papillon et al.
Nucleic acids research, 41(16), 7815-7827 (2013-06-28)
Type 2A DNA topoisomerases (Topo2A) remodel DNA topology during replication, transcription and chromosome segregation. These multisubunit enzymes catalyze the transport of a double-stranded DNA through a transient break formed in another duplex. The bacterial DNA gyrase, a target for broad-spectrum
Pieter Dewint et al.
Gut, 63(2), 292-299 (2013-03-26)
To assess whether a combination of adalimumab and ciprofloxacin is superior to adalimumab alone in the treatment of perianal fistulising Crohn's disease (CD). Randomised, double-blind, placebo controlled trial in eight Dutch hospitals. In total, 76 CD patients with active perianal
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico